Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Beatriz Grinsztejn(Instituto Evandro Chagas), Mina C. Hosseinipour(University of North Carolina at Chapel Hill), Heather J. Ribaudo(Harvard University), Susan Swindells(University of Nebraska Medical Center), Joseph J. Eron(University of North Carolina at Chapel Hill), Ying Qing Chen(Fred Hutch Cancer Center), Lei Wang(Fred Hutch Cancer Center), San-San Ou(Fred Hutch Cancer Center), Maija Anderson(Fred Hutch Cancer Center), Marybeth McCauley(Family Health International 360), Theresa Gamble(Family Health International 360), N. Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), James Hakim(University of Zimbabwe), Johnstone Kumwenda(University of Malawi), José Henrique Pilotto(Hospital Geral de Fortaleza), Sheela Godbole(National AIDS Research Institute), Suwat Chariyalertsak(Chiang Mai University), Marineide Gonçalves de Melo(Hospital Nossa Senhora da Conceição), Kenneth H. Mayer(Fenway Health), Susan H. Eshleman(Johns Hopkins Medicine), Estelle Piwowar‐Manning(Johns Hopkins University), Joseph Makhema(Botswana Harvard AIDS Institute Partnership), Lisa Mills(Kenya Medical Research Institute), Ravindre Panchia(University of the Witwatersrand), Ian Sanne(University of the Witwatersrand), Joel E. Gallant(Johns Hopkins Medicine), Irving Hoffman(University of North Carolina at Chapel Hill), Taha E. Taha(Johns Hopkins University), Karin Nielsen‐Saines(University of California, Los Angeles), David D. Celentano(Johns Hopkins University), Max Essex(Harvard University), Diane V. Havlir(University of California, San Francisco), Myron S. Cohen(University of North Carolina at Chapel Hill)
Cited by 511Open Access
Abstract
Related Papers
Treatment of latent tuberculosis infection in HIV infected persons
Christopher Akolo, Ifedayo Adetifa, Sasha Shepperd et al.|Cochrane Database of Systematic Reviews|2010|718